Status:
COMPLETED
Comparative Formulation Study of Vabicaserin
Lead Sponsor:
Wyeth is now a wholly owned subsidiary of Pfizer
Conditions:
Healthy Subjects
Eligibility:
MALE
18-50 years
Phase:
PHASE1
Brief Summary
This study will compare two different formulations of vabicaserin.
Eligibility Criteria
Inclusion
- Sexually active men must agree to use a medically acceptable form of contraception during the study and continue it for 12 weeks after investigational product administration.
- Nonsmoker or smoker of fewer than 10 cigarettes per day as determined by history. Must be able to abstain from smoking during the inpatient stay.
Exclusion
- Use of any investigational or prescription drug within 30 days before investigation product administration.
- Consumption of any caffeine-containing products (eg, coffee, tea, chocolate, or soda) or alcoholic beverages within 48 hours before study day 1.
- Use of any over-the-counter drugs, including herbal supplements within 72 hours before study day 1.
Key Trial Info
Start Date :
June 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2009
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT00928551
Start Date
June 1 2009
End Date
September 1 2009
Last Update
September 11 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Brighton, Massachusetts, United States, 2135